Development of Schamberg's disease after  SARS‐CoV ‐2 vaccination | Zendy

Morimoto Hiroki | Zendy; Ogura Yasuaki | Zendy; Otsuka Masaki | Zendy; Hayano Satoshi | Zendy; Tokura Yoshiki | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development of Schamberg's disease after SARS‐CoV ‐2 vaccination

Author(s) -

Morimoto Hiroki,

Ogura Yasuaki,

Otsuka Masaki,

Hayano Satoshi,

Tokura Yoshiki

Publication year - 2022

Publication title -

journal of cutaneous immunology and allergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.127

H-Index - 1

ISSN - 2574-4593

DOI - 10.1002/cia2.12247

Subject(s) - vaccination , medicine , buttocks , purpura (gastropod) , disease , population , immunology , pathology , surgery , biology , ecology , environmental health

Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research